ACRA entity record
- Legal name
- Ami Biomedical
- UEN
- 53442747B
- Entity type
- Sole Proprietorship/ Partnership
- Status
- Deregistered
- Incorporated
- 18-Nov-2021
Ami Biomedical
- Status
- Deregistered
- Incorporated
- 18-Nov-2021
- Jurisdiction
- Singapore
FIND ANOTHER COMPANY
Search all ten markets
- Revenue
- Locked In full report
- Net Profit
- Locked In full report
- UEN
- 53442747B ACRA record
- Legal Type
- Sole Proprietorship/ Partnership ACRA record
- Established
- 18-Nov-2021 ACRA record
- Age
- 4 Years Calculated today
Ami Biomedical is a sole proprietorship/ partnership, incorporated on 18-Nov-2021 in Singapore. The Company's principal business is not stated in the ACRA record. Ami Biomedical has been registered for 4 years and its current ACRA status is Deregistered.
Profile
Registered contact information
- Registered Address
- Selegie Road, 188307
- Operational address
- Locked
- Website
- Locked
- Telephone
- Locked
People
Premium Access
Management checks for Ami Biomedical
Officer names, appointments, and signing authority require premium access.
- Current and former officers
- Appointments and signing authority
Premium Access
Shareholder checks for Ami Biomedical
Ownership records and shareholder relationships require premium access.
- Shareholder names and holdings
- Ownership percentages and changes
Financial
Premium Access
Credit Rating checks for Ami Biomedical
Credit assessment and supporting financial indicators require premium access.
- Credit rating and payment profile
- Financial strength and risk indicators
Risk
Premium Access
Government Connection checks for Ami Biomedical
Government ownership, control, and politically exposed person links require premium access.
- Government ownership and control checks
- Politically exposed person links
Premium Access
Litigation checks for Ami Biomedical
Court records and material dispute intelligence require premium access.
- Singapore court and dispute records
- Case status and material outcomes
Premium Access
Regulatory checks for Ami Biomedical
Regulatory actions, sanctions, and compliance findings require premium access.
- Regulatory actions and sanctions
- Licence and compliance findings
Premium Access
Adverse Media checks for Ami Biomedical
Source-screened media coverage and reputational risk signals require premium access.
- Source-screened media coverage
- Material allegations and reputational signals